Eva Hernando
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Aging top 0.5%
Papers in
-
- Circular RNAs in diseases 14
- Melanoma and MAPK Pathways 13
- RNA Interference and Gene Delivery 11
- Protein Degradation and Inhibitors 11
-
- MicroRNA in disease regulation 29
- Cancer-related molecular mechanisms research 17
- Co-authors
- Carlos Cordon‐Cardo (21 shared papers)Scott W. Lowe (10 shared papers)Michael T. Hemann (5 shared papers)Gregory J. Hannon (4 shared papers)David Mu (3 shared papers)Valery Krizhanovsky (3 shared papers)Lars Zender (3 shared papers)Scott M. Hammond (2 shared papers)
- Journals
- Cancer Research (8 papers)Journal of Clinical Oncology (7 papers)Nature (5 papers)Pigment Cell & Melanoma Research (5 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Eva Hernando
113 papers receiving 14.9k citations
Eva Hernando's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 5.2k
- Aging 303
- Molecular Biology 10.0k
- Oncology 3.1k
- Immunology 1.9k
Countries citing papers authored by Eva Hernando
This map shows the geographic impact of Eva Hernando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hernando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hernando more than expected).
Fields of papers citing papers by Eva Hernando
This network shows the impact of papers produced by Eva Hernando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hernando. The network helps show where Eva Hernando may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Hernando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A microRNA polycistron as a potential human oncogene Hit paper breakdown → | 2005 | 3001 |
| 2 | Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Hit paper breakdown → | 2007 | 2002 |
| 3 | Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence Hit paper breakdown → | 2008 | 1446 |
| 4 | Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice Hit paper breakdown → | 2006 | 500 |
| 5 | 2009 | 475 | |
| 6 | 2004 | 465 | |
| 7 | 2008 | 353 | |
| 8 | 2010 | 302 | |
| 9 | 2011 | 301 | |
| 10 | 2003 | 300 | |
| 11 | 2017 | 244 | |
| 12 | 2020 | 242 | |
| 13 | 2007 | 229 | |
| 14 | 2007 | 215 | |
| 15 | 2013 | 194 | |
| 16 | 2010 | 186 | |
| 17 | 2014 | 169 | |
| 18 | 2008 | 165 | |
| 19 | 2004 | 162 | |
| 20 | 2007 | 162 |
About Eva Hernando
Eva Hernando is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 117 papers that have together received 15.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (17 papers), Circular RNAs in diseases (14 papers), Melanoma and MAPK Pathways (13 papers), RNA Interference and Gene Delivery (11 papers), Protein Degradation and Inhibitors (11 papers), Cutaneous Melanoma Detection and Management (10 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Cancer Research (5.2k citations), Aging (303 citations), Molecular Biology (10.0k citations), Oncology (3.1k citations) and Immunology (1.9k citations). Eva Hernando has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Carlos Cordon‐Cardo, Scott W. Lowe, Michael T. Hemann, Gregory J. Hannon, David Mu, Valery Krizhanovsky, Lars Zender, Scott M. Hammond, Scott Powers and Lin He. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Nature, Pigment Cell & Melanoma Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.